CREBBP and neoplasm: TCGA material reported a pathogenetic or unknown variant rate of only 2% for IDCs, but in rare adenoid cystic carcinomas of the breast, 31% of tumours have shown CREBBP pathogenetic or unknown variants [12, 49].